2seventy bio (NASDAQ:TSVT) reported quarterly losses of $(0.81) per share which met the analyst consensus estimate. This is a 25 percent increase over losses of $(1.08) per share from the same period last year. The company reported quarterly sales of $12.44 million which missed the analyst consensus estimate of $14.08 million by 11.68 percent. This is a 70.12 percent decrease over sales of $41.62 million the same period last year.
2seventy Bio Q1 Adj $(0.81), Inline, Sales $12.44M Miss $14.08M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.